日本語English简体中文 繁體中文

4886 ASKA Pharmaceutical Holdings Co.,Ltd.あすか製薬ホールディングスTSE Prime / Pharmaceuticals

0 posts

ASKA Pharmaceutical Holdings Co.,Ltd. (4886) at a glance

Code
4886
Company
ASKA Pharmaceutical Holdings Co.,Ltd.
Local name
あすか製薬ホールディングス
Market
TSE Prime
Sector
Pharmaceuticals
Share price
¥2,072 -60.0 (-2.81%) Nov 20 close

Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.

ASKA Pharmaceutical Holdings Co.,Ltd. (4886) Stock Price History

ASKA Pharmaceutical Holdings Co.,Ltd. closed at ¥2,072 on Nov 20, 2026, +3.4% over 1 month, +2.0% over 1 year.

2026-11-04 2027年3月期 第2四半期(中間期)決算短信〔日本基準〕(連結) / 2027年3月期 第2四半期決算短信補足資料¥2,190¥1,948Oct 20Nov 20
Price5-day MA25-day MANikkei 225Disclosures
1-Month High¥2,190Nov 12
1-Month Low¥1,948Nov 4
1-Week Change−4.1%vs Nov 13
1-Month Change+3.4%vs Oct 20

If you had invested ¥100,000 1 month ago, it would be worth ¥103,393 today (+3.4%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −11.9%, while this stock moved +3.4%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)¥2,072−60−2.81%
Nov 19 (Thu)¥2,132+7+0.33%
Nov 18 (Wed)¥2,125−29−1.35%
Nov 17 (Tue)¥2,154−26−1.19%
Nov 16 (Mon)¥2,180+20+0.93%
Nov 13 (Fri)¥2,160−30−1.37%
Nov 12 (Thu)¥2,190+41+1.91%
Nov 11 (Wed)¥2,149+26+1.22%
Nov 10 (Tue)¥2,123+39+1.87%
Nov 9 (Mon)¥2,084+58+2.86%
2026-11-04 2027年3月期 第2四半期(中間期)決算短信〔日本基準〕(連結) / 2027年3月期 第2四半期決算短信補足資料¥2,227¥1,948Aug 20Nov 20
Price5-day MA25-day MANikkei 225Disclosures
3-Month High¥2,227Aug 20
3-Month Low¥1,948Nov 4
1-Month Change+3.4%vs Oct 20
3-Month Change−7.0%vs Aug 20

If you had invested ¥100,000 3 months ago, it would be worth ¥93,040 today (−7.0%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −14.8%, while this stock moved −7.0%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)¥2,072−60−2.81%
Nov 19 (Thu)¥2,132+7+0.33%
Nov 18 (Wed)¥2,125−29−1.35%
Nov 17 (Tue)¥2,154−26−1.19%
Nov 16 (Mon)¥2,180+20+0.93%
Nov 13 (Fri)¥2,160−30−1.37%
Nov 12 (Thu)¥2,190+41+1.91%
Nov 11 (Wed)¥2,149+26+1.22%
Nov 10 (Tue)¥2,123+39+1.87%
Nov 9 (Mon)¥2,084+58+2.86%
2026-11-04 2027年3月期 第2四半期(中間期)決算短信〔日本基準〕(連結) / 2027年3月期 第2四半期決算短信補足資料¥2,995¥1,948May 20Nov 20
Price25-day MA75-day MANikkei 225Disclosures
6-Month High¥2,995May 25
6-Month Low¥1,948Nov 4
3-Month Change−7.0%vs Aug 20
6-Month Change−27.1%vs May 20

If you had invested ¥100,000 6 months ago, it would be worth ¥72,906 today (−27.1%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −5.6%, while this stock moved −27.1%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥2,072+4.3%
Oct 2026¥1,986−3.4%
Sep 2026¥2,056−2.8%
Aug 2026¥2,115−1.7%
Jul 2026¥2,151−6.6%
Jun 2026¥2,302−21.4%
May 2026¥2,930+0.5%
2026-11-04 2027年3月期 第2四半期(中間期)決算短信〔日本基準〕(連結) / 2027年3月期 第2四半期決算短信補足資料¥2,995¥1,929Nov 20Nov 20
Price25-day MA75-day MANikkei 225Disclosures
52-Week High¥2,995May 25
52-Week Low¥1,929Dec 5
Year to Date+1.7%vs Dec 30
From 52-Week High−30.8%May 25

If you had invested ¥100,000 1 year ago, it would be worth ¥101,969 today (+2.0%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +13.3%, while this stock moved +2.0%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥2,072+4.3%
Oct 2026¥1,986−3.4%
Sep 2026¥2,056−2.8%
Aug 2026¥2,115−1.7%
Jul 2026¥2,151−6.6%
Jun 2026¥2,302−21.4%
May 2026¥2,930+0.5%
Apr 2026¥2,916+23.6%
Mar 2026¥2,360−5.3%
Feb 2026¥2,492−0.2%
Jan 2026¥2,498+22.6%
Dec 2025¥2,038−0.8%
Nov 2025¥2,055―
¥2,992¥1,742Nov 20, 2023Nov 20, 2026
Price13-week MA26-week MANikkei 225
3-Year High¥2,992Apr 24, 2026
3-Year Low¥1,742Dec 18, 2023
Annualized Return+4.8%
Max Drawdown−33.6%

If you had invested ¥100,000 3 years ago, it would be worth ¥115,111 today (+15.1%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +67.8%, while this stock moved +15.1%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥2,072+1.7%
2025¥2,038―
¥2,992¥948Nov 22, 2021Nov 20, 2026
Price13-week MA26-week MANikkei 225
5-Year High¥2,992Apr 24, 2026
5-Year Low¥948Nov 29, 2021
Annualized Return+15.5%
Max Drawdown−33.6%

If you had invested ¥100,000 5 years ago, it would be worth ¥205,352 today (+105.4%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +96.3%, while this stock moved +105.4%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥2,072+1.7%
2025¥2,038―
¥2,992¥935Mar 29, 2021Nov 20, 2026
Price1-year MA2-year MANikkei 225
All-Time High¥2,992Apr 2026
All-Time Low¥935Jul 2021
Total Change+41.0%vs Mar 2021
Annualized Return+6.3%

If you had invested ¥100,000 in Mar 2021, it would be worth ¥141,048 today (+41.0%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +93.4%, while this stock moved +41.0%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥2,072+1.7%
2025¥2,038−2.9%
2024¥2,099+17.7%
2023¥1,784+37.5%
2022¥1,297+28.8%
2021¥1,007―

Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Mar 2021). Please check the latest prices before trading.

ASKA Pharmaceutical Holdings Co.,Ltd. (4886) financial indicators

PER
12.3
PBR
0.80
ROE
6.56%
Dividend yield
3.14%

See all financial indicators for ASKA Pharmaceutical Holdings Co.,Ltd. (market cap, DOE, equity ratio, EV, EBITDA, ROIC and more)

PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.

Key features of ASKA Pharmaceutical Holdings Co.,Ltd. (4886)

Business overview

The company is a holding company established in April 2021 as the wholly owning parent of 「あすか製薬」, operating together with five subsidiaries and six affiliates. Its four segments are pharmaceuticals, animal health, overseas and others. The pharmaceutical business mainly makes and sells prescription drugs. The animal health business makes and sells veterinary drugs, feed additives and more. In the overseas business, overseas subsidiaries mainly make and sell prescription drugs. Other businesses include clinical testing and medical devices.

Summarized from the annual securities report (fiscal year ended March 2026) filed on EDINET.

Position within Pharmaceuticals (79 companies)

Dividend yield3.14%No. 17 in the sector (highest first); median 2.97%
PER12.3xBelow the sector median of 16.5x (No. 12 from the lowest)
PBR0.80xBelow the sector median of 1.86x (No. 10 from the lowest)
ROE6.56%No. 21 in the sector (highest first); median 4.17%
Market cap¥58.9 bnNo. 28 in the sector (largest first)

Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.

Price milestones

52-week high¥2,9955/25
52-week low¥1,9292025/12/5
Current position13.4%Where the low is 0% and the high is 100% (close on 11/20: ¥2,072)
Year to date+1.7%No. 14 of 77 in the sector (best first)
1 year+2.0%

Based on closing prices (adjusted for stock splits, excluding dividends).

Kabutaro's ranking history

Top 50 gainers1 timesLatest: 11/5 (No. 50)

Gainers and losers have been recorded since 9/2026.

Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.

Recent disclosures (TDnet, in Japanese)

Filings from the past 12 months (4).

Posts

This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.

No posts yet. Be the first to write something.

Write on the ASKA Pharmaceutical Holdings Co.,Ltd. board

You will need this to delete your post. Please keep it safe.
By posting you agree to the board rules (Japanese). You are responsible for what you write.

More Japanese stocks in English

Japanese Stock Message Board: stocks available in English

Other boards in English